gene therapy-based I-O drug development

With professional service and various advanced equipment at Creative Biolabs, GTOnco™ platform provides high-quality preclinical profiling and monitoring of immune responses for gene therapy-based I-O drug development. Utilizing the most effective combination of assays available to identify promising I-O therapeutics, our broad range of well-established assays and animal models allow clients to choose the most appropriate study design and screening method to identify the best option and optimize lead candidates.

0 Replies:

Leave a Reply

Your email address will not be published. Required fields are marked *